Both species are common colonisers of the human urogenital tract. Carriage rates of 40–80% have been reported in sexually active adults[6][10]. Most people never notice. But under the right conditions — pregnancy, immune stress, co-infection, or simply imbalance in the genital microbiome — Ureaplasma has been linked to clinically meaningful disease.
What the science actually says
The literature is nuanced: Ureaplasma is best understood as a conditional pathogen. Associations with disease are strongest for U. urealyticum, while U. parvum is more often (but not always) a commensal[4][8]. The conditions where it crosses from "guest" to "pathogen" are well documented in peer-reviewed reviews:
- Non-gonococcal urethritis in men, particularly with high bacterial loads[8][12].
- Adverse pregnancy outcomes — preterm birth, chorioamnionitis, premature rupture of membranes[3][7].
- Neonatal disease, including pneumonia and bronchopulmonary dysplasia in preterm infants[1][2].
- Reduced semen quality and male-factor infertility in some studies[9].
- Pelvic inflammatory disease and chronic pelvic pain, often in combination with Mycoplasma hominis[6].
Why the silence is the problem
Because most carriers feel nothing, Ureaplasma is often discovered only after a downstream issue appears — recurrent miscarriage, struggling to conceive, persistent urethritis, a preterm birth. The bacteria themselves are easy to detect with modern PCR, but you have to actually look for them. Routine STI panels in many countries do not include them[4].
What this site is — and isn't
We summarise peer-reviewed literature in plain English. Every claim links to PubMed or a public-health authority such as the CDC, so you can read the primary source yourself. We are not your doctor. If something on this site concerns you, talk to a clinician.